
News|Articles|November 9, 2010
Nonanthracycline regimens for adjuvant treatment of operable breast cancer
Nonanthracycline-containing chemotherapy regimens for the adjuvant treatment of operable stage I to III breast cancer are discussed, including efficacy and toxicity results from recent randomized clinical trials comparing anthracycline to nonanthracycline-containing regimens.
Advertisement
Nonanthracycline-containing chemotherapy regimens for the adjuvant treatment of operable stage I to III breast cancer are discussed, including efficacy and toxicity results from recent randomized clinical trials comparing anthracycline to nonanthracycline-containing regimens.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Top 5 stories from Formulary Watch in 2025
2
Top 5 articles about drug and healthcare costs in 2025
3
What NCCN’s next CMO sees ahead for cancer guidelines, access and innovation
4
Jascayd gets second FDA approval, this time for progressive pulmonary fibrosis
5





















































